BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33538260)

  • 1. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar.
    Cicero AFG; Fogacci F; Zambon A
    J Am Coll Cardiol; 2021 Feb; 77(5):620-628. PubMed ID: 33538260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red Yeast Rice for Hypercholesterolemia.
    Cicero AFG; Fogacci F; Banach M
    Methodist Debakey Cardiovasc J; 2019; 15(3):192-199. PubMed ID: 31687098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Red yeast rice, monacolin K, and pleiotropic effects.].
    Cicero AFG
    Recenti Prog Med; 2018 Feb; 109(2):154e-157e. PubMed ID: 29493648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review.
    Cicero AFG; Fogacci F; Stoian AP; Toth PP
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention.
    Heinz T; Schuchardt JP; Möller K; Hadji P; Hahn A
    Nutr Res; 2016 Oct; 36(10):1162-1170. PubMed ID: 27865358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
    Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
    J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis.
    Gerards MC; Terlou RJ; Yu H; Koks CH; Gerdes VE
    Atherosclerosis; 2015 Jun; 240(2):415-23. PubMed ID: 25897793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of the Consumption of the Nutraceutical "Red Yeast Rice Extract" for the Reduction of Hypercholesterolemia in Humans: A Systematic Review and Meta-Analysis.
    Trogkanis E; Karalexi MA; Sergentanis TN; Kornarou E; Vassilakou T
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic rats.
    Bunnoy A; Saenphet K; Lumyong S; Saenphet S; Chomdej S
    BMC Complement Altern Med; 2015 Mar; 15():88. PubMed ID: 25880551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
    Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
    Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial.
    Angelopoulos N; Paparodis RD; Androulakis I; Boniakos A; Argyrakopoulou G; Livadas S
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monacolin K supplementation in patients with hypercholesterolemia: A systematic review of clinical trials.
    Liasi E; Kantilafti M; Hadjimbei E; Chrysostomou S
    Semergen; 2024; 50(4):102156. PubMed ID: 38310834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
    Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
    Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia.
    Ogier N; Amiot MJ; Georgé S; Maillot M; Mallmann C; Maraninchi M; Morange S; Lescuyer JF; Peltier SL; Cardinault N
    Eur J Nutr; 2013 Mar; 52(2):547-57. PubMed ID: 22527287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Powdered red yeast rice and plant stanols and sterols to lower cholesterol.
    Feuerstein JS; Bjerke WS
    J Diet Suppl; 2012 Jun; 9(2):110-5. PubMed ID: 22531006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence.
    Barrios V; Escobar C; Cicero AF; Burke D; Fasching P; Banach M; Bruckert E
    Atheroscler Suppl; 2017 Feb; 24():1-15. PubMed ID: 27998714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
    Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
    Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
    Becker DJ; Gordon RY; Halbert SC; French B; Morris PB; Rader DJ
    Ann Intern Med; 2009 Jun; 150(12):830-9, W147-9. PubMed ID: 19528562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.
    Verhoeven V; Lopez Hartmann M; Remmen R; Wens J; Apers S; Van Royen P
    BMC Complement Altern Med; 2013 Jul; 13():178. PubMed ID: 23866314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.